Abstract

Clinically relevant in vivo models for atopic dermatitis (AD) are needed, in which the minimal signals required for AD induction in human skin can be defined and candidate therapeutics explored. Here, we report a novel humanized AD mouse model that uses split-thickness skin from healthy, non-atopic female human donors xenotransplanted onto SCID/beige mice and injected with autologous, Th2-polarized PBMCs. After intradermal injection of PBMCs preincubated only with IL-2, IL-4 and LPS, the xenotransplants develop a phenocopy of human AD lesions, including epidermal hyperplasia, hyperproliferation, erythema, and skin barrier impairment (reduced filaggrin and claudin-1 expression, altered corneocyte nanotexture [atomic force miocroscopy]).

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.